Company intelligence / Profile preview
Tilde Sciences
Jersey City, New Jersey, United States
- Ownership
- Private
- Employees
- ~11
- Development stage
- Other
01
Overview
Tilde Sciences currently commercializes two specialty pharmaceuticals targeting rare diseases with significant unmet needs: VECAMYL (mecamylamine) for severe and malignant hypertension, and Daraprim (pyrimethamine) for toxoplasmosis. Both are FDA-approved and distributed through exclusive specialty pharmacy partnerships.[3][4][6]
- Therapeutic areas
- Infectious DiseasesCardiovascular
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
AscellaHealth (Optime Care)
Beyond the preview
Go deeper on Tilde Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tilde Sciences.